Translational Genomics Research Institute: Ashion Analytics Announces Innovative Cancer Treatment Partnership With Elevation Oncology
July 23, 2020
July 23, 2020
PHOENIX, Arizona, July 23 -- The Translational Genomics Research Institute issued the following news release:
Ashion Analytics LLC announced a partnership with Elevation Oncology, a clinical stage biopharmaceutical company, focused on the matching of patients with tumors harboring an NRG1 gene fusion identified using Ashion's proprietary GEM ExTra(R) test with CRESTONE, a registration-directed Phase 2 study sponsored by Elevation Oncology.
NRG1 gene fusions are a rare g . . .
Ashion Analytics LLC announced a partnership with Elevation Oncology, a clinical stage biopharmaceutical company, focused on the matching of patients with tumors harboring an NRG1 gene fusion identified using Ashion's proprietary GEM ExTra(R) test with CRESTONE, a registration-directed Phase 2 study sponsored by Elevation Oncology.
NRG1 gene fusions are a rare g . . .